Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic.
D000161:Acoustic Stimulation; D000613:Aminobutyrates / Q000097:blood / Q000633:toxicity; D000818:Animals; D001806:Blood Urea Nitrogen; D002415:Cats; D003051:Cochlea / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006311:Hearing Disorders / Q000139:chemically induced; D007612:Kanamycin / Q000097:blood / Q000633:toxicity*; D007674:Kidney Diseases / Q000139:chemically induced; D009467:Neuromuscular Depolarizing Agents; D014677:Pharmaceutical Vehicles; D014722:Vestibule, Labyrinth / Q000187:drug effects
D000613:Aminobutyrates; D009467:Neuromuscular Depolarizing Agents; D014677:Pharmaceutical Vehicles; D007612:Kanamycin